Learn, Analyse & Invest
only with
only with
+91
Download Orca
Novateor Research Laboratories Ltd.
Novateor Research
₹ 0.00
0.00 (0.00)%
NSE
BSE
FMCG
Small-cap - With a market cap of ₹18.89 Cr.
| EX-Date | Purpose |
|---|---|
| 30 06 2021 | Audited Results |
| 03 09 2021 | A.G.M. |
| 14 11 2021 | Half Yearly Results |
| 30 05 2022 | Audited Results |
| 01 09 2022 | Inter alia, to consider and approve the following businesses: 1. To consider and approve the Draft Directors? Report and annexure thereof, of the company for the financial year 2021-22. 2. To consider and fix day, date, time and venue and Notice for Annual General Meeting of the Company. 3. To fix the Record date for the ensuing Annual General Meeting. 4. Consider matters relating to the ensuing Annual General Meeting of the Company. 5. To appoint Mr. Jitin Jaysukh Doshi(DIN: 07325340) as Additional Non-Executive Director of the company 6. To transact any other matter with prior approval of chairman. |
| 14 11 2022 | Half Yearly Results |
| 30 05 2023 | Audited Results |
| 23 08 2023 | Issue Of Warrants & Increase in Authorised Capital & A.G.M. |
| 26 08 2023 | Issue Of Warrants & Increase in Authorised Capital & A.G.M. |
| 06 11 2023 | Inter alia, to consider and approve:- 1. To consider and approve the resolution to increase the authorized share capital of the company and subsequent change in the Memorandum of Association of the company. 2. Raising of funds by way of issue of equity shares /convertible warrants to Promoters/ Promoters Group and to persons other than the Promoters/Promoter Group on preferential basis, subject to obtaining the approval of the shareholders of the Company. 3. To consider and approve the resignation of Mr. Sindhav Vipulbhai (DIN: 08595440) as an independent Non Executive Director of the company with effect from 7th November, 2023 4. To consider and approve the reappointment of Managing Director, Whole time Director and Independent Directors of the company. 5. To consider and approve the matter related to ensuing Extra Ordinary General Meeting of the company. 6. To transact any other businesses with prior approval of chairman. |
| 14 11 2023 | Half Yearly Results |
| 14 11 2024 | Half Yearly Results |
| 30 05 2025 | Audited Results |
| 03 09 2025 | A.G.M. |
| 14 11 2025 | Half Yearly Results |
News
